CliniSpan Health brings diversification to clinical health trials
by Abbey Slattery
Clinical health trials are a key step in ensuring that new treatments and drugs are safe and effective for the general public. The participants in these trials are intended to represent the population that will be using the drug, but many are severely lacking in diversity.
Data from the United States Food and Drug Administration shows African-Americans only account for 5 percent of clinical trial participants, while Latino Americans make up just 1 percent.
For many minorities, that means the side effects of certain medications aren’t known before they’re released to the general population.Read More